{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,20]],"date-time":"2026-06-20T05:44:01Z","timestamp":1781934241935,"version":"3.54.5"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T00:00:00Z","timestamp":1761004800000},"content-version":"vor","delay-in-days":293,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["IDCases"],"published-print":{"date-parts":[[2025]]},"DOI":"10.1016\/j.idcr.2025.e02407","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:43:46Z","timestamp":1761187426000},"page":"e02407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Melioidosis clinically unresponsive to meropenem in a traveller returning from Thailand"],"prefix":"10.1016","volume":"42","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9714-0725","authenticated-orcid":false,"given":"Ilka","family":"Grewe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette","family":"Hennigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaminia","family":"Olearo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylyn M.","family":"Addo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ramharter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabine","family":"Jordan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.idcr.2025.e02407_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/nmicrobiol.2015.8","article-title":"Predicted global distribution of burkholderia pseudomallei and burden of melioidosis","volume":"1","author":"Limmathurotsakul","year":"2016","journal-title":"Nat Microbiol"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02407_bib2","doi-asserted-by":"crossref","first-page":"316","DOI":"10.3201\/eid2502.170745","article-title":"Clinical manifestations, antimicrobial drug susceptibility patterns, and outcomes in melioidosis cases, India","volume":"25","author":"Koshy","year":"2019","journal-title":"Emerg Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02407_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/infdis\/168.5.1181","article-title":"Relapse in melioidosis: incidence and risk factors","volume":"168","author":"Chaowagul","year":"1993","journal-title":"J Infect Dis"},{"issue":"8","key":"10.1016\/j.idcr.2025.e02407_bib4","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1086\/507632","article-title":"Risk factors for recurrent melioidosis in northeast Thailand","volume":"43","author":"Limmathurotsakul","year":"2006","journal-title":"Clin Infect Dis"},{"issue":"8665","key":"10.1016\/j.idcr.2025.e02407_bib5","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0140-6736(89)90768-X","article-title":"Halving of mortality of severe melioidosis by ceftazidime","volume":"2","author":"White","year":"1989","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02407_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1016\/j.ijantimicag.2014.01.005","article-title":"Treatment and prophylaxis of melioidosis","volume":"43","author":"Dance","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02407_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-023-00972-5","article-title":"Burkholderia pseudomallei and melioidosis","volume":"22","author":"Meumann","year":"2024","journal-title":"Nat Rev Microbiol"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02407_bib8","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/315306","article-title":"Differential antibiotic-induced endotoxin release in severe melioidosis","volume":"181","author":"Simpson","year":"2000","journal-title":"J Infect Dis"},{"issue":"5","key":"10.1016\/j.idcr.2025.e02407_bib9","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1128\/AAC.48.5.1763-1765.2004","article-title":"Outcomes of patients with melioidosis treated with meropenem","volume":"48","author":"Cheng","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02407_bib10","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1086\/520219","article-title":"Comparison of imipenem and ceftazidime as therapy for severe melioidosis","volume":"29","author":"Simpson","year":"1999","journal-title":"Clin Infect Dis"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02407_bib11","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/cid\/ciy069","article-title":"Raising the stakes: loss of efflux pump regulation decreases meropenem susceptibility in burkholderia pseudomallei","volume":"67","author":"Sarovich","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"12","key":"10.1016\/j.idcr.2025.e02407_bib12","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/S1473-3099(21)00022-0","article-title":"The Darwin prospective melioidosis study: a 30-year prospective, observational investigation","volume":"21","author":"Currie","year":"2021","journal-title":"Lancet Infect Dis"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02407_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.4269\/ajtmh.23-0369","article-title":"Case report: risk factors associated with mortality in adults with burkholderia pseudomallei bacteremia: a retrospective case series of melioidosis in Cambodia","volume":"111","author":"Pacheco","year":"2024","journal-title":"Am J Trop Med Hyg"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02407_bib14","doi-asserted-by":"crossref","first-page":"783","DOI":"10.47665\/tb.37.3.783","article-title":"Reduced susceptibility of burkholderia pseudomallei following exposure to carbapenem","volume":"37","author":"Zamani","year":"2020","journal-title":"Trop Biomed"},{"issue":"4","key":"10.1016\/j.idcr.2025.e02407_bib15","article-title":"Five-year surveillance for burkholderia pseudomallei in Thailand from 2000 to 2004: prevalence and antimicrobial susceptibility","volume":"92","author":"Paveenkittiporn","year":"2009","journal-title":"J Med Assoc Thai"},{"issue":"2","key":"10.1016\/j.idcr.2025.e02407_bib16","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.ijantimicag.2014.04.012","article-title":"Current antimicrobial susceptibility of first-episode melioidosis burkholderia pseudomallei isolates from the Northern Territory, Australia","volume":"44","author":"Crowe","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"9","key":"10.1016\/j.idcr.2025.e02407_bib17","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000014461","article-title":"Molecular epidemiology and antibiotic resistance of burkholderia pseudomallei isolates from hainan, China: a STROBE compliant observational study","volume":"98","author":"Rao","year":"2019","journal-title":"Med (Baltim)"},{"issue":"3","key":"10.1016\/j.idcr.2025.e02407_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1093\/jac\/37.3.611","article-title":"In-vitro activity of carbapenem antibiotics against beta-lactam susceptible and resistant strains of burkholderia pseudomallei","volume":"37","author":"Smith","year":"1996","journal-title":"J Antimicrob Chemother"},{"issue":"41","key":"10.1016\/j.idcr.2025.e02407_bib19","doi-asserted-by":"crossref","first-page":"17165","DOI":"10.1073\/pnas.1111020108","article-title":"Antimicrobial resistance to ceftazidime involving loss of penicillin-binding protein 3 in burkholderia pseudomallei","volume":"108","author":"Chantratita","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"10.1016\/j.idcr.2025.e02407_bib20","doi-asserted-by":"crossref","first-page":"S145","DOI":"10.1016\/S0035-9203(08)70032-4","article-title":"Expression of resistance-nodulation-cell-division efflux pumps in commonly used burkholderia pseudomallei strains and clinical isolates from Northern Australia","volume":"102","author":"Kumar","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/j.idcr.2025.e02407_bib21","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jgar.2025.05.006","article-title":"Emergence of ceftazidime resistance in burkholderia pseudomallei during therapy: clinical, phenotypic and genotypic insights from paired isolates","volume":"43","author":"Suchartlikitwong","year":"2025","journal-title":"J Glob Antimicrob Resist"}],"container-title":["IDCases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092500263X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221425092500263X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T09:04:50Z","timestamp":1773219890000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221425092500263X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":21,"alternative-id":["S221425092500263X"],"URL":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02407","relation":{},"ISSN":["2214-2509"],"issn-type":[{"value":"2214-2509","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Melioidosis clinically unresponsive to meropenem in a traveller returning from Thailand","name":"articletitle","label":"Article Title"},{"value":"IDCases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.idcr.2025.e02407","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e02407"}}